A Parotid Gland Mammary Analogue Secretory Carcinoma in a 4-Year-Old Boy: Case Report and Literature Review

References

• Skalova A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, Starek I, Geierova M, Simpson RH, Passador-Santos F, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34(5):599–608. doi:10.1097/PAS.0b013e3181d9efcc.
   PubMed Web of Science ®Google Scholar
• Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, Macpherson N, Horsman D, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2(5):367–76. doi:10.1016/S1535-6108(02)00180-0.
   PubMed Web of Science ®Google Scholar
• Majewska H, Skalova A, Stodulski D, Klimkova A, Steiner P, Stankiewicz C, Biernat W. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement. Virchows Arch. 2015;466(3):245–54. doi:10.1007/s00428-014-1701-8.
   PubMed Web of Science ®Google Scholar
• Church AJ, Calicchio ML, Nardi V, Skalova A, Pinto A, Dillon DA, Gomez-Fernandez CR, Manoj N, Haimes JD, Stahl JA, et al. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy. Mod Pathol. 2018;31(3):463–73. doi:10.1038/modpathol.2017.127.
   PubMed Web of Science ®Google Scholar
• Knezevich SR, Mcfadden DE, Tao W, Lim JF, Sorensen PH. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet. 1998;18(2):184–7. doi:10.1038/ng0298-184.
   PubMed Web of Science ®Google Scholar
• De Braekeleer E, Douet-Guilbert N, Morel F, Le Bris MJ, Basinko A, De Braekeleer M. ETV6 fusion genes in hematological malignancies: a review. Leuk Res. 2012;36(8):945–61. doi:10.1016/j.leukres.2012.04.010.
   PubMed Web of Science ®Google Scholar
• Eguchi M, Eguchi-Ishimae M, Tojo A, Morishita K, Suzuki K, Sato Y, Kudoh S, Tanaka K, Setoyama M, Nagamura F, et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood. 1999;93(4):1355–63. doi:10.1182/blood.V93.4.1355.
   PubMed Web of Science ®Google Scholar
• Alassiri AH, Ali RH, Shen Y, Lum A, Strahlendorf C, Deyell R, Rassekh R, Sorensen PH, Laskin J, Marra M, et al. ETV6-NTRK3 is expressed in a subset of ALK-negative inflammatory myofibroblastic tumors. Am J Surg Pathol. 2016;40(8):1051–61. doi:10.1097/PAS.0000000000000677.
   PubMed Web of Science ®Google Scholar
• Rubin BP, Chen C-J, Morgan TW, Xiao S, Grier HE, Kozakewich HP, Perez-Atayde AR, Fletcher JA. Congenital mesoblasticnephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol. 1998;153(5):1451–8. doi:10.1016/S0002-9440(10)65732-X.
   PubMed Web of Science ®Google Scholar
• Huang T, Mchugh JB, Berry GJ, Myers JL. Primary mammary analogue secretory carcinoma of the lung: a case report. Hum Pathol. 2018;74:109–13. doi:10.1016/j.humpath.2017.10.027.
   PubMed Web of Science ®Google Scholar
• Khurram SA, Sultan-Khan J, Atkey N, Speight PM. Cytogenetic and immunohistochemical characterization of mammary analogue secretory carcinoma of salivary glands. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(6):731–42. doi:10.1016/j.oooo.2016.07.008.
   PubMed Web of Science ®Google Scholar
• Sethi R, Kozin E, Remenschneider A, Meier J, Vanderlaan P, Faquin W, Deschler D, Frankenthaler R. Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy. Laryngoscope. 2014;124(1):188–95. doi:10.1002/lary.24254.
   PubMed Web of Science ®Google Scholar
• Salgado CM, Alaggio R, Reyes-Mugica M, Zin A, de Vito R. Clinicopathologic and molecular characterization of four cases of pediatric salivary secretory carcinoma (SSC), one with ETV6-RET fusion. Head Neck Pathol. 2021;15(3):796–802. doi:10.1007/s12105-021-01288-7.
   PubMed Web of Science ®Google Scholar
• Vasanthi V, Ramadoss R. Secretory carcinoma of salivary gland - A systematic review of pediatric case reports and case series. J Oral Maxillofac Pathol. 2021;25(2):327–31. doi:10.4103/0973-029X.325236.
   PubMedGoogle Scholar
• Ngouajio AL, Drejet SM, Phillips DR, Summerlin DJ, Dahl JP. A systematic review including an additional pediatric case report: Pediatric cases of mammary analogue secretory carcinoma. Int J Pediatr Otorhinolaryngol. 2017;100:187–93. doi:10.1016/j.ijporl.2017.07.004.
   PubMed Web of Science ®Google Scholar
• Skalova A, Vanecek T, Simpson RH, Laco J, Majewska H, Baneckova M, Steiner P, Michal M. Mammary analogue secretory carcinoma of salivary glands: molecular analysis of 25 ETV6 gene rearranged tumors with lack of detection of classical ETV6-NTRK3 fusion transcript by standard RT-PCR: report of 4 cases harboring ETV6-X gene fusion. Am J Surg Pathol. 2016;40(1):3–13. doi:10.1097/PAS.0000000000000537.
   PubMed Web of Science ®Google Scholar
• Bishop JA, Yonescu R, Batista DA, Westra WH, Ali SZ. Cytopathologic features of mammary analogue secretory carcinoma. Cancer Cytopathol. 2013;121(5):228–33. doi:10.1002/cncy.21245.
   PubMed Web of Science ®Google Scholar
• Griffith CC, Stelow EB, Saqi A, Khalbuss WE, Schneider F, Chiosea SI, Seethala RR. The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases. Cancer Cytopathol. 2013;121(5):234–41. doi:10.1002/cncy.21249.
   PubMed Web of Science ®Google Scholar
• Chiosea SI, Griffith C, Assaad A, Seethala RR. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am J Surg Pathol. 2012;36(3):343–50. doi:10.1097/PAS.0b013e318242a5b0.
   PubMed Web of Science ®Google Scholar
• Connor A, Perez-Ordonez B, Shago M, Skalova A, Weinreb I. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol. 2012;36(1):27–34. doi:10.1097/PAS.0b013e318231542a.
   PubMed Web of Science ®Google Scholar
• Luo W, Lindley SW, Lindley PH, Krempl GA, Seethala RR, Fung KM. Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature. Int J Clin Exp Pathol. 2014;7(12):9008–22.
   PubMed Web of Science ®Google Scholar
• Strauss BL, Bratthauer GL, Tavassoli FA. STAT 5a expression in the breast is maintained in secretory carcinoma, in contrast to other histologic types. Hum Pathol. 2006;37(5):586–92. doi:10.1016/j.humpath.2006.01.009.
   PubMed Web of Science ®Google Scholar
• Chiosea SI, Griffith C, Assaad A, Seethala RR. Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands. Histopathology. 2012;61(3):387–94. doi:10.1111/j.1365-2559.2012.04232.x.
   PubMed Web of Science ®Google Scholar
• Ozguroglu M, Tascilar K, Ilvan S, Soybir G, Celik V. Secretory carcinoma of the breast. Case report and review of the literature. Oncology. 2005;68(2-3):263–8. doi:10.1159/000086782.
   PubMed Web of Science ®Google Scholar
• Wai DH, Knezevich SR, Lucas T, Jansen B, Kay RJ, Sorensen PH. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Oncogene. 2000;19(7):906–15. doi:10.1038/sj.onc.1203396.
   PubMed Web of Science ®Google Scholar
• Gonzalez MF, Akhtar I, Manucha V. Additional diagnostic features of mammary analogue secretory carcinoma on cytology. Cytopathology. 2018;29(1):100–3. doi:10.1111/cyt.12465.
   PubMed Web of Science ®Google Scholar
• Levine P, Fried K, Krevitt LD, Wang B, Wenig BM. Aspiration biopsy of mammary analogue secretory carcinoma of accessory parotid gland: another diagnostic dilemma in matrix-containing tumors of the salivary glands. Diagn Cytopathol. 2014;42(1):49–53. doi:10.1002/dc.22886.
   PubMed Web of Science ®Google Scholar
• Skálová A, Vanecek T, Martinek P, et al. Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases. Am J Surg Pathol. 2018;42(2):234–246. doi:10.1097/PAS.0000000000000972.
   PubMed Web of Science ®Google Scholar
• Guilmette J, Dias-Santagata D, Nose V, Lennerz JK, Sadow PM. Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family. Hum Pathol. 2019;83:50–8. doi:10.1016/j.humpath.2018.08.011.
   PubMed Web of Science ®Google Scholar
• Rooper LM, Karantanos T, Ning Y, Bishop JA, Gordon SW, Kang H. Salivary secretory carcinoma with a novel ETV6-MET fusion: expanding the molecular spectrum of a recently described entity. Am J Surg Pathol. 2018;42(8):1121–6. doi:10.1097/PAS.0000000000001065.
   PubMed Web of Science ®Google Scholar
• Ito Y, Ishibashi K, Masaki A, Fujii K, Fujiyoshi Y, Hattori H, Kawakita D, Matsumoto M, Miyabe S, Shimozato K, et al. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion. Am J Surg Pathol. 2015;39(5):602–10. doi:10.1097/PAS.0000000000000392.
   PubMed Web of Science ®Google Scholar
• Drilon A. TRK inhibitors in TRK fusion-positive cancers. Ann Oncol. 2019;30(Suppl_8):i23–30. doi:10.1093/annonc/mdz282.
   Google Scholar
• Li AY, Mccusker MG, Russo A, Scilla KA, Gittens A, Arensmeyer K, Mehra R, Adamo V, Rolfo C. RET fusions in solid tumors. Cancer Treat Rev. 2019;81:101911. doi:10.1016/j.ctrv.2019.101911.
   PubMed Web of Science ®Google Scholar
• Skalova A, Vanecek T, Majewska H, Laco J, Grossmann P, Simpson RH, Hauer L, Andrle P, Hosticka L, Branzovsky J, et al. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, beta-catenin, EGFR, and CCND1 genes. Am J Surg Pathol. 2014;38(1):23–33. doi:10.1097/PAS.0000000000000088.
   PubMed Web of Science ®Google Scholar